NCT02932592View on ClinicalTrials.gov

evAluation of Glycemic RangE During acutE Coronary syndroME in Nondiabetic paTients (AGREEMENT)

PHASE4CompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

March 16, 2016

Primary Completion Date

March 25, 2017

Study Completion Date

October 31, 2017

Conditions
Acute Coronary Syndrome
Interventions
DEVICE

Continuous Glucose Monitoring System (i Pro 2 - Medtronic)

This device can register blood glucose values and excursions. This device consists of a needle (applied in subcutaneous way) and of a recording device.

Trial Locations (1)

27100

Giuseppe Derosa, Pavia

All Listed Sponsors
lead

University of Pavia

OTHER

NCT02932592 - evAluation of Glycemic RangE During acutE Coronary syndroME in Nondiabetic paTients (AGREEMENT) | Biotech Hunter | Biotech Hunter